Weeks after its competitor Moderna, Pfizer has asked regulators to authorize a three-dose Covid-19 vaccine for children under 5.
Weeks after its competitor Moderna, Pfizer has asked regulators to authorize a three-dose Covid-19 vaccine for children under 5.